Current Cardiovascular Risk Reports
Overview
Current Cardiovascular Risk Reports is a scientific journal, published by Springer since 2006 in English. The journal's country of origin is United States and its primary focus area is cardiology & vascular diseases.
Details
Details
Abbr.
Curr Cardiovasc Risk Rep
Publisher
Springer
Start
2006
End
Continuing
Frequency
Bimonthly
p-ISSN
1932-9520
e-ISSN
1932-9563
Country
United States
Language
English
Specialty
Cardiology & Vascular Diseases
Metrics
Metrics
h-index / Ranks: 9739
34
SJR / Ranks: 9031
491
CiteScore / Ranks: 10462
2.10
Recent Articles
1.
Doherty S, Hernandez S, Rikhi R, Mirzai S, De Los Reyes C, McIntosh S, et al.
Curr Cardiovasc Risk Rep
. 2025 Feb;
19(1):8.
PMID: 39980866
Purpose Of Review: Lipoprotein(a) [Lp(a)], an atherogenic low-density lipoprotein cholesterol (LDL-C)-like molecule, has emerged as an important risk factor for the development of atherosclerotic cardiovascular disease (ASCVD). This review summarizes...
2.
Perez S, Thandra S, Mellah I, Kraemer L, Ross E
Curr Cardiovasc Risk Rep
. 2024 Nov;
18(12):187-195.
PMID: 39552745
Purpose Of Review: Peripheral Artery Disease (PAD), a condition affecting millions of patients, is often underdiagnosed due to a lack of symptoms in the early stages and management can be...
3.
Chhabria S, LeBron J, Ronis S, Batt C
Curr Cardiovasc Risk Rep
. 2024 Aug;
18(8-9):115-124.
PMID: 39105085
Purpose Of Review: Hypertension (HTN) and obesity are increasing in prevalence and severity in adolescents and have significant implications for long term morbidity and mortality. This review focuses on the...
4.
Scott S, Gouchoe D, Azap L, Henn M, Choi K, Mokadam N, et al.
Curr Cardiovasc Risk Rep
. 2024 Aug;
18(7):95-113.
PMID: 39100592
Purpose Of Review: Despite efforts to curtail its impact on medical care, race remains a powerful risk factor for morbidity and mortality following cardiac surgery. While patients from racial and...
5.
Verbrugge F, Vangoitsenhoven R, Mullens W, Van der Schueren B, Mathieu C, Tang W
Curr Cardiovasc Risk Rep
. 2024 Jul;
9(8).
PMID: 38994329
Sodium-glucose transporter-2 (SGLT-2) inhibitors have emerged as novel oral glucose-lowering agents for type 2 diabetes. SGLT-2 inhibitors improve glycemic control by blocking sodium-glucose cotransport in the renal proximal tubules, thereby...
6.
Raghban A, Kirsop J, Tang W
Curr Cardiovasc Risk Rep
. 2024 Jul;
9(1).
PMID: 38993263
Patients with chronic kidney disease (CKD) have heightened risk of developing heart failure (HF), yet few clinical studies have directly investigated the pathophysiologic underpinnings or therapeutic strategies to prevent HF....
7.
Aksu T, Chung M
Curr Cardiovasc Risk Rep
. 2024 May;
18(4):55-64.
PMID: 38707611
Purpose Of Review: Cardioneuroablation (CNA) has emerged as a potential alternative to pacemaker therapy in well-selected cases with vasovagal syncope (VVS). In recent years, the number of CNA procedures performed...
8.
Hughes Z, Hughes L, Khan S
Curr Cardiovasc Risk Rep
. 2024 Jan;
17(11):185-193.
PMID: 38186860
Purpose Of Review: Adverse pregnancy outcomes (APOs), including hypertensive disorders of pregnancy (HDP), low birthweight (LBW), and preterm birth (PTB), along with peripartum cardiomyopathy (PPCM) are associated with short- and...
9.
Azizi Z, Adedinsewo D, Rodriguez F, Lewey J, Merchant R, Brewer L
Curr Cardiovasc Risk Rep
. 2023 Oct;
17(11):205-214.
PMID: 37868625
Purpose Of Review: In this review, we present a comprehensive discussion on the population-level implications of digital health interventions (DHIs) to improve cardiovascular health (CVH) through sex- and gender-specific prevention...
10.
Vandenberk B, Raj S
Curr Cardiovasc Risk Rep
. 2023 Jun;
17(6):103-115.
PMID: 37305214
Purpose Of Review: Remote monitoring (RM) of cardiac implantable electronic devices (CIEDs) is an important part of patient follow-up. The increasing number of patients with CIEDs and the recent pandemic...